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COMMENTARY
The Folate Debate
Robert L. Brent, MD, PhDa, Godfrey P. Oakley, Jr, MD, MSPMb
aDepartment of Pediatrics, Radiology, and Pathology, Thomas Jefferson University, A.I. duPont Hospital for Children, Wilmington, Delaware; bDepartment of
Epidemiology, Rollins School of Public Health of Emory University, Atlanta, Georgia
Financial Disclosure: Dr Brent owns no stock in companies that make or distribute folic acid or sell or distribute grains. Some of his research that is supported by the National Institutes of Health has dealt with
the use of folic acid to prevent neural tube defects as well as the metabolism of folic acid and methionine. Dr Oakley is a co-inventor of a patent that covers adding folic acid to contraceptive pills (while at the
Centers for Disease Control and Prevention, compensation, if any, will be under the regulations of the Centers for Disease Control and Prevention) and has been a consultant to Ortho McNeil on this issue.
NO INFANT ANYWHERE in the world should die fromanencephaly or be paralyzed by spina bifida be-
cause he or she was conceived and developed in a folate-
deficient environment.1,2 The Medical Research Council
Vitamin Study Research Group’s randomized, controlled
trial showed in 1991 that pregnant women who con-
sume enough synthetic folic acid before and during the
early weeks of pregnancy do not have infants with folic
acid–preventable spina bifida and anencephaly.3 There
has been unconscionable and unnecessary delay in the
implementation of the public health and nutrition poli-
cies and programs necessary to prevent all of these pre-
ventable birth defects.2,4–8 As a result of these delays, 3
million children have been unnecessarily paralyzed or
have died. It is past the time when all governments
should have implemented programs to prevent all folic
acid–preventable spina bifida and anencephaly.
A group of scientists, parents, and policy advocates
met at the Ottawa, Canada, headquarters of Micronutri-
ent Initiative and produced recommendations for in-
creasing the pace for prevention of folic acid–prevent-
able spina bifida and other folic acid–preventable
diseases. They recommended mandatory folic acid flour
fortification as the foundation on which to build this
birth defects–prevention program, because in many
countries the consumption of wheat and/or corn flour
provides the opportunity to prevent birth defects by
requiring mills to fortify flour with folic acid.8
In the United States, consumption of wheat and corn
flour with adequate enrichment of folic acid can provide
the opportunity for near-total, if not total, prevention of
these severe birth defects that are preventable through
fortification. The decision of the US Food and Drug
Administration (FDA) to require “folic acid–enriched”
grain products such as wheat and corn flour provided
the basis for a marked improvement of public health and
has provided an example that 40 countries have em-
ulated.
In their special article in this issue of Pediatrics, Rader
and Schneeman9 note the improvement in serum and
red cell folates that occurred after fortification, yet they
write that “it is not possible to determine if these values
are sufficiently high to protect all women at risk.” Said
another way, we do not have the evidence that would
permit us to conclude that the developing embryos of all
pregnant women are being protected; therefore, we do
not have the evidence to conclude that all folic acid–
preventable spina bifida and anencephaly are being pre-
vented.
The current US Public Health Service and the current
Institute of Medicine (IOM) recommendations are that
all women of reproductive age should consume 400 g
of synthetic folic acid daily to prevent these birth de-
fects.10,11 There is evidence to suggest that the median
folic acid consumption of women of reproductive age
may be as much as 200 g of synthetic folic acid per day
postfortification,12,13 which means that most women are
not getting the 400 g that is recommended. Increasing
the concentration of folic acid required in “enriched”
grains would increase the proportion of women who
would consume the recommended amount of folic acid
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and increase the prevention of folic acid–preventable
neural tube defects. We may not know the exact number
of cases of spina bifida and anencephaly that would be
prevented by increasing fortification; however, that fact
should not stop the FDA from moving quickly to require
an increase in the concentration of folic acid.
We encourage the FDA to implement a process that
would provide for an open, fair, and rapid assessment of
the available data and consider implementing the rec-
ommendations of the IOM for folic acid intake through
fortification of enriched cereal grains. The primary ques-
tion to be addressed should be, what additional contri-
butions to the total prevention of folic acid–preventable
spina bifida should the FDA initiate through changes in
enrichment regulations? Because the IOM has recom-
mended that all people 50 years consume 2.4 g of
synthetic vitamin B12 to prevent vitamin B12 deficiency,
the review should also deliberate the issue of vitamin B12
deficiency and determine what contribution to prevent-
ing vitamin B12 deficiency the FDA can make by requir-
ing the addition of vitamin B12 in enriched grains.11 We
think that when such a review is completed, the FDA
will increase the folic acid concentration in enriched
grains and require that vitamin B12 be added.14 These
actions would improve the health of our nation’s chil-
dren and adults.
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